Two Sigma Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Two Sigma Investments’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,556	Closed	-$432K	–	3446
2023 Q3	$432K	Sell	2,556 -4,580	-64%	-$861K	﹤0.01%	2338
2023 Q2	$1.55M	Buy	7,136 +33	+0.5%	+$7.07K	﹤0.01%	1662
2023 Q1	$1.29M	Sell	7,103 -100,737	-93%	-$19.3M	﹤0.01%	1728
2022 Q4	$21.2M	Sell	107,840 -102,122	-49%	-$21.9M	0.07%	340
2022 Q3	$47.2M	Buy	+209,962	New	+$42.5M	0.16%	160
2021 Q4	–	Sell	-14,700	Closed	-$1.8M	–	5045
2021 Q3	$1.8M	Sell	14,700 -8,803	-37%	-$1.02M	﹤0.01%	2089
2021 Q2	$2.68M	Buy	+23,503	New	+$2.75M	0.01%	1640
2021 Q1	–	Sell	-6,742	Closed	-$685K	–	4347
2020 Q4	$685K	Sell	6,742 -32,264	-83%	-$2.99M	﹤0.01%	2276
2020 Q3	$3.02M	Buy	39,006 +28,159	+260%	+$2.4M	0.01%	1062
2020 Q2	$1.21M	Buy	+10,847	New	+$943K	0.01%	1413

Other funds holding KRTX

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Two Sigma Investments's KRTX Position: Q4 2023 in Review

Two Sigma Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2023, closing a stake of 2,556 shares — an estimated $432K sold.

Two Sigma Investments first reported a position in KRTX in Q2 2020 and held it in 10 quarters. The position peaked at $47.2M in Q3 2022. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

Two Sigma Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Two Sigma Investments sold 2,556 Karuna Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $432K.
Two Sigma Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Two Sigma Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $47.2M in Q3 2022.
328 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.